Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products and Demonstrating the Substantial Equivalence of a New Tobacco Product: Responses to Frequently Asked Questions, 10250 [2016-04222]
Download as PDF
10250
Federal Register / Vol. 81, No. 39 / Monday, February 29, 2016 / Notices
enhance the quality, utility, and clarity
of the information to be collected; and
ways in which we can minimize the
burden of the collection of information
on those who are to respond, through
the use of appropriate technological
collection techniques or other forms of
information technology.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street NW., Washington, DC
20405, telephone 202–501–4755.
Please cite OMB Control No. 9000–
0070, Payments, in all correspondence.
Dated: February 23, 2016.
Lorin S. Curit,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
[FR Doc. 2016–04280 Filed 2–26–16; 8:45 am]
BILLING CODE 6820–EP–P
Dated: February 19, 2016.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2016–04297 Filed 2–26–16; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: February 23, 2016.
Leslie Kux,
Associate Commissioner for Policy.
Food and Drug Administration
[FR Doc. 2016–04222 Filed 2–26–16; 8:45 am]
BILLING CODE 4164–01–P
[Docket No. FDA–2011–D–0147]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Guidance for Industry and Food and
Drug Administration Staff; Section
905(j) Reports: Demonstrating
Substantial Equivalence for Tobacco
Products and Demonstrating the
Substantial Equivalence of a New
Tobacco Product: Responses to
Frequently Asked Questions
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[CDC–2013–0025; Docket Number NIOSH–
266]
Issuance of Final Publication
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
AGENCY:
Notice of issuance of final
publication.
ACTION:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
announces the availability of the
following publication: NIOSH Criteria
for a Recommended Standard:
Occupational Exposure to Heat and Hot
Environments [2016–106].
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
This document may be
obtained at the following link: https://
www.cdc.gov/niosh/docs/2016-106/.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Brenda Jacklitsch, NIOSH Education
and Information Division, 1090
Tusculum Ave, Mail Stop C–32,
Cincinnati, OH 45226, email address:
gwe6@cdc.gov.
VerDate Sep<11>2014
19:23 Feb 26, 2016
Jkt 238001
Notice.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Guidance for Industry and Food and
Drug Administration Staff; Section
905(j) Reports: Demonstrating
Substantial Equivalence for Tobacco
Products and Demonstrating the
Substantial Equivalence of a New
Tobacco Product: Responses to
Frequently Asked Questions’’ has been
approved by the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
On July
16, 2015, the Agency submitted a
proposed collection of information
entitled ‘‘Guidance for Industry and
Food and Drug Administration Staff;
Section 905(j) Reports: Demonstrating
Substantial Equivalence for Tobacco
Products and Demonstrating the
Substantial Equivalence of a New
Tobacco Product: Responses to
Frequently Asked Questions’’ to OMB
for review and clearance under 44
U.S.C. 3507. An Agency may not
conduct or sponsor, and a person is not
required to respond to, a collection of
information unless it displays a
currently valid OMB control number.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00046
Fmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–1093]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Food Additive
Petitions and Investigational Food
Additive Exemptions
AGENCY:
SUMMARY:
Centers for Disease Control and
Prevention
OMB has now approved the information
collection and has assigned OMB
control number 0910–0673. The
approval expires on January 31, 2019. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
Sfmt 4703
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by March 30,
2016.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0546. Also
include the FDA docket number found
in brackets in the heading of this
document.
SUMMARY:
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\29FEN1.SGM
29FEN1
Agencies
[Federal Register Volume 81, Number 39 (Monday, February 29, 2016)]
[Notices]
[Page 10250]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04222]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-D-0147]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Guidance for Industry and Food and
Drug Administration Staff; Section 905(j) Reports: Demonstrating
Substantial Equivalence for Tobacco Products and Demonstrating the
Substantial Equivalence of a New Tobacco Product: Responses to
Frequently Asked Questions
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Guidance for Industry and Food and
Drug Administration Staff; Section 905(j) Reports: Demonstrating
Substantial Equivalence for Tobacco Products and Demonstrating the
Substantial Equivalence of a New Tobacco Product: Responses to
Frequently Asked Questions'' has been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: On July 16, 2015, the Agency submitted a
proposed collection of information entitled ``Guidance for Industry and
Food and Drug Administration Staff; Section 905(j) Reports:
Demonstrating Substantial Equivalence for Tobacco Products and
Demonstrating the Substantial Equivalence of a New Tobacco Product:
Responses to Frequently Asked Questions'' to OMB for review and
clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor,
and a person is not required to respond to, a collection of information
unless it displays a currently valid OMB control number. OMB has now
approved the information collection and has assigned OMB control number
0910-0673. The approval expires on January 31, 2019. A copy of the
supporting statement for this information collection is available on
the Internet at https://www.reginfo.gov/public/do/PRAMain.
Dated: February 23, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-04222 Filed 2-26-16; 8:45 am]
BILLING CODE 4164-01-P